CD36 and metabolic dysfunction-associated steatotic liver disease: As a target gene of PPARγ, hepatic CD36 is associated with human and murine NAFLD by enhancing the fatty acid uptake capacity (Wheeler and Gekakis, 2014; Wilson et al., 2016).